Skip to main content
. 2020 Nov 17;184(2):267–276. doi: 10.1530/EJE-20-0325

Figure 2.

Figure 2

Effect of rhIGF1 therapy on height SDS (A), height velocity (B), BMI SDS (C), and weight SDS (D) in treatment-naïve/prepubertal (NPP) patients with or without LS (registry population). Data are mean (s.d.). n, number of patients with available data at each time point; LS, Laron syndrome; SDS, standard deviation score.